Introduction
The increased availability of imaging equipment has increased the detection of renal masses. It is estimated that more than half of patients over the age of 50 years have at least one renal mass [1, 2] . The most common malignant mass is renal cell carcinoma, which represents about 2% of adult cancers. Transitional cell carcinoma (TCC), lymphoma, melanoma, and metastases are other types of malignant masses. Benign tumors account for approximately 20% of all solid renal cortical tumors; angiomyolipoma (AML) and renal oncocytoma are the most common types [3] . Treatment is important for malignant tumors; it is also appropriate for symptomatic AMLs among the benign ones [4, 5] .
There is a wide range of management options for renal masses, including radiological follow-up, radiofrequency ablation, cryoablation, partial nephrectomy, and radical nephrectomy. About 27% of small enhancing renal masses are found to be benign at surgery [6] . Thus, the characterization of lesions and staging of renal masses are vital for the management of patients. However, the precise diagnosis of renal masses remains a major problem. Investigators have looked for accurate imaging methods for the pathological subtyping of renal masses [7] [8] [9] . Ultrasound (US), as a first-line imaging technique, is important for detecting renal tumors and discriminating between benign and malignant lesions. Dynamic contrast-enhanced computer tomography (CT) and magnetic resonance imaging (MRI) are now commonly used for these. Unfortunately, both imaging techniques have some disadvantages. For example,high doses of radiation are inevitable in dynamic CT scans, although the exact dose varies according to the scanner and size of the patient. Patients with cardiac pacemakers, metallic clips that may cause artifacts, and those suffering from claustrophobia may not be appropriate for MRI. The use of CT and MRI contrast agents may be partially or completely restricted in patients with renal insufficiency and solitary kidney, and this may interfere with the noninvasive diagnosis of renal masses in such patients. Contrast-enhanced US serves as a good alternative for patients with renal insufficiency or allergy to iodinated contrast agents in detecting benign and malignant solid renal lesions [10] .
Percutaneous core biopsy is a minimally invasive method for establishing a definitive diagnosis for indeterminate lesions, such as infections and lymphoma, and for confirming the origin of metastatic diseases. Renal mass biopsies are often avoided because of possible complications, such as bleeding, perirenal hematoma, hematuria, arteriovenous fistula formation, and pneumothorax [11] . The risk of tumor seeding, especially of TCC, is another concern.
Thus, it is important to identify another noninvasive and reliable method to distinguish between benign and malignant renal lesions. Shear-wave elastography (SWE) is a procedure for assessing tissue stiffness without external compression [12, 13] . An acoustic radiation force is used to generate low-frequency (~50 Hz) mechanical (shear) waves that induce tissue displacement. This technique quantitatively calculates stiffness values in regions of interest.
There are many reports on the accuracy of elastography for diagnosing solid lesions of the breast [14] , thyroid [15, 16] , liver [17] , prostate [18] , rectum [19] , and lymph nodes [20] . However, to the best of our knowledge, few studies have evaluated the success of US elastography for increasing the sensitivity of conventional US for discriminating between benign and malignant renal masses [21] [22] [23] [24] [25] . In this study, we investigated the diagnostic accuracy of SWE for assessing malignant and benign kidney masses.
Material and method

Patients and imaging procedures
The study was designed in a prospective manner and approved by the Ethics Committee of our institution. Each participant gave written and oral consent. From September 2014 to March 2015, 40 patients who were referred to our institution for further evaluation of a renal mass, or had been diagnosed with a renal mass during a surveillance examination (US, CT, or MRI) at our institution underwent US elastographic evaluations. The values obtained through SWE were compared to the histopathologic examination or follow-up results.
The 40 patients consisted of 23 (57.5%) females, the mean age was 50.13±16.72 (range 4-85 years) for women and 50.64±16.06 (range 12-81 years) for men, and the mean body mass index was 26.69±3.09 kg/m 2 (range 19.4-30.8 kg/m 2 ).
B-mode imaging and SWE measurements were made using US equipment (Philips iU22; Eindhoven, the Netherlands) and a curved array probe (C5-1 PureWave transducer), performed by a radiology specialist (SA) with 5 years of US and 3 years of SWE experience. The patients avoided eating for 8 hours before the examination. The patients were examined in the supine, right, or left oblique position, as required. Size, internal echo pattern, contour, and shape of lesions were assessed in B-mode imaging. For quantitative evaluations of stiffness by SWE, the patients were requested to stop breathing, rather than taking a deep breath, because the box for the ROI can be placed in tissues only as deep as 7 cm. The ROI size was fixed depending on the properties of the selected equipment. The lesion was targeted in the B-mode image and the box for ROI was placed in the solid and most echogenic parts of the lesion. Care was taken to avoid placing the ROI in cystic parts or calcifications in the lesion. For interpretation of the SWE ratio (SWER), measurements were obtained from adjacent renal cortex. It is obtained by dividing the mean SWE value of the tumor by that of adjacent renal cortex (SWER = SWE tumor / SWE cortex ). The ROI was positioned carefully to avoid partial effects from the renal medulla or pelvis. Elastography values were quantified in kilopascals (kPa). At least three measurements were performed for each lesion to ensure the quality of SWE, and the highest value was used in statistical analyses (fig 1, fig 2) .
Statistical analysis
The SPSS software (ver. 19 ) was used to analyze the data. Data are presented as means, standard deviations (SD), and percentages. The lesions were explored in two groups according to the lesion size as <3cm or ≥3 cm. The independent-sample t-test was used for two-group comparisons of homogenic variances. The Mann-Whitney U-test was used to compare quantitative variables of groups 1 and 2 because they showed heterogeneous variance. Categorical variables were evaluated with the χ 2 test. The significance level was set at 0.05.
Results
Malignant tumors were recorded as group 1 and benign tumors were recorded as group 2. The mean size was 5.23±3.42 cm for group 1 and 4.26±2.56 cm for group 2. There were no significant differences between tumor sizes of the two groups.
Each patient had one renal lesion. Thus, 40 lesions were assessed by SWE. The lesions were clear cell RCC (n=17), chromophobe RCC (n=1), TCC (n=2), liposarcoma (n=2), Wilms tumor (n=1), metastasis (n=2), angiomyolipoma (n=9), cystic nephroma (n=2), oncocytoma (n=1), xanthogranulomatous pyelonephritis (n=1), abscess (n=1), and hematoma (n=1). The RCCs, TCCs, liposarcomas, Wilms tumor, cystic nephromas, oncocytoma, and xanthogranulomatous pyelonephritis were diagnosed histopathologically, by partial or radical nephrectomy. The abscess and two metastases were confirmed by sampling, and the hematoma was confirmed by drainage. Eight angiomyolipomas were assessed during follow-up of a previous diagnosis. Only one minimal fat angiomyolipoma, misdiagnosed as RCC by imaging, was confirmed after resection.
The highest elasticity values were 27.27±25.66 kPa for group 1 and 16.13±8.89 kPa for group 2; the dif- Measurements of the renal cortex did not significantly differ between kidneys with malignant and benign lesions. The mean±SD elasticity values for adjacent renal cortex for groups 1 and 2 were 2.7±2.08 and 2.75±1.35, respectively.
SWER was detected for each lesion by dividing the highest stiffness value in the lesion by the highest value in the adjacent renal cortex. SWER did not significantly differ between the groups. However, there was a positive correlation between SWER and the highest SWE value of the masses for each group (p=0.006, rs=0.534 for group 1 and p=0.018, rs=0.6 for group 2).
For group 1 a negative correlation was observed between the age of the patients and SWER value (p=0.047, rs=-0.401). There was also a negative correlation between the SWER value and the SWE value of adjacent renal cortex (p=0.004, rs=-0.555).
Discussions
US is generally used to detect renal solid tumors but is rarely the only method used to characterize solid renal masses. It is usually not possible to discriminate between benign and malignant tumors based on B-mode findings because of the overlapping US features [9, 26, 27] .
SWE is a recently developed technique that provides quantitative measurements of tissue elasticity. The major advantages of SWE versus other US elastography techniques are that it provides true elasticity values of tissues (in kPa) and does not need external compression. Thus, it is a more useful method for investigating the elasticity of visceral organs. Few studies have evaluated the elasticity of renal tumors [21] [22] [23] [24] [25] . To the best of our knowledge, there are only five such reports in the English language literature (two regarding strain elastography and three regarding ARFI elastography). Cut-off values for benign and malignant tumors have not yet been validated.
Onur et al [21] used strain elastography to assess solid renal tumors, and found that benign masses had a lower mean strain index values than malignant ones (p<0.0001); malignant tumors were 2.8 times stiffer than benign tumors. Elasticity significantly differs between normal and neoplastic tissues. One reason for the increased stiffness of lesions may be linked to increased cellularity due to increased mitosis. In our study, malignant renal tumors had slightly (but not significantly) higher (~1.6 times higher) elasticity values than benign renal tumors. A possible reason for the different results across studies may be the different US devices used.
Onur et al [21] and Tan et al [22] compared elastography values of RCC and AML histotypes, and both reported a significant difference in elasticity between the two tumor types (p<0.0001 and p<0.001, respectively). We obtained higher elasticity values for RCC than angiomyolipomas, consistent with previous research. RCCs were 1.8 times stiffer than angiomyolipomas.
In general, elasticity values of benign lesions are lower than malignant tissues and higher than normal tissues. However, there may be overlaps that need to be identified to improve the diagnostic performance of US elastography. Goya et al [25] found significant differences in elasticity between benign and malignant renal cortical tumors (p=0.033). However, the SWE values of TCC were similar to those of benign cortical lesions. In our study, the mean elasticity values of TCCs were similar to those of AMLs. TCC is a challenging tumor when it involves the upper collecting system, and particularly when it is small. Histologically, TCC is a soft, fern-like tumor with loose connective tissue. These histological features may influence its mechanical properties. The RCCs and the abscess in our study also had similar elasticity values. Abscesses and inflammatory conditions in other parts of the body generally have lower elasticity values than normal tissues and malignant lesions. Our result might be due to the stage of the abscess. Before the liquefaction process, swelling and induration occur in the tissue, which may cause higher elasticity values. Thus, additional findings beyond an elastographic evaluation are needed for the diagnosis of an abscess.
SWER is another parameter for assessing the stiffness of tissue quantitatively in elastography. SWER has been used in breast [28] and prostate [29] imaging to differentiate malignant tumors from benign ones. Lu et al [23] used SWER values to discriminate between benign and malignant renal tumors in a large series that included 201 renal lesions (44 benign, 157 malignant). They found that mean SWER and SWE values of AML were significantly lower relative to RCC of any histotype: 1.92±0.85 versus 2.27±0.85 (p=0.022) and 0.74±0.34 versus 1.10±0.52 (p<0.001), respectively. We found that SWER values of RCCs were higher than those of AMLs (although the differences were not statistically significant), consistent with the results of Lu et al. We found a negative correla-tion between age and SWER for malignant tumors. This might be due to cortical elasticity decreasing with age. If renal parenchymal elastography values change with age, this might cause SWER to be a less valuable measure. Normative values for SWER relative to age may need to be determined. The utility of SWER versus SWE for discriminating between malignant and benign renal tumors needs to be investigated with a larger series.
The kidney differs from other visceral organs in structural and functional characteristics. The proximal and distal collecting tubules, vascular structures, calyces, and pelvis are major structures in its unique anatomy. This anatomical arrangement causes anisotropic delineation, making the kidney different from hepatic and prostatic tissue in SWE. Anisotropy is assumed to influence shear wave velocity, which may cause under-or overestimation of elastography values. Changes in vascularisation may reduce elasticity measurements of the kidney, or renal fibrosis secondary to chronic renal diseases may cause increased elasticity [30] . Further studies are required to establish normal and pathologic values of different anatomic regions of the kidney.
Our study had some limitations. First, we studied a limited patient population. In some lesion histotypes, the n value was only 1. Second, we did not take into consideration the subtypes of RCC or minimal fat angiomyolipoma. Elasticity changes between subtypes of RCC and fat-poor and fat-rich angiomyolipomas may be subjects for future studies. Third, the ROI size was constant, which could have impacted some of the parenchymal measurements. Newer technologies can overcome this, with the development of free hand ROIs. Finally, we did not assess inter-or intraobserver variability, but the method has been shown to be highly reproducible.
In conclusion, SWE is a noninvasive method that provides quantitative elasticity information on tissues. Overlaps among different types of renal lesions may be due to heterogeneity of the lesions, rather than the method itself. Larger study groups may clarify the other factors affecting SWE values under both normal and pathological conditions.
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